GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nutriband Inc (FRA:9WV) » Definitions » Momentum Rank

Nutriband (FRA:9WV) Momentum Rank : 0 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nutriband Momentum Rank?

Nutriband has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Nutriband Momentum Rank Related Terms

Thank you for viewing the detailed overview of Nutriband's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutriband (FRA:9WV) Business Description

Traded in Other Exchanges
Address
121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Nutriband (FRA:9WV) Headlines

No Headlines